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Summary 
Protein kinases regulate a multitude of processes by reversible phosphorylation of 
target molecules. Induction of cell proliferation and differentiation are fundamental to 
development and rely on tightly controlled kinase activities. Vaccinia-Related 
Kinases (VRKs) have emerged as a multifunctional family of kinases with essential 
functions conserved, from nematodes and fruit flies, to humans. VRK substrates 
include chromatin and transcription factors, whereas deregulation of VRKs is 
implicated in sterility, cancer and neurological defects. In contrast to previous 
observations, we describe here that Caenorhabditis elegans VRK-1 is expressed in all 
cell types, including proliferating and post-mitotic cells. Despite the ubiquitous 
expression pattern, we find that vrk-1 mutants are particularly impaired in uterine 
development. Our data show that VRK-1 is required for uterine cell proliferation and 
differentiation. Moreover, the anchor cell, a specialized uterine cell, fails to fuse with 
neighboring cells to form the utse syncytium in vrk-1 mutants, thus providing further 
insight on the role of VRKs in organogenesis.  
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1. Introduction 
Elucidation of organogenesis is important in order to understand development of 
multicellular organisms, and the Caenorhabditis elegans egg-laying apparatus serves 
as an excellent model for studying mechanisms underlying cell fate specification and 
intercellular signaling pathways (Gupta et al., 2012). 
During C. elegans development, in late L2 larval stage, two developmentally 
equivalent cells of the somatic gonad primordium, called Z1.ppp and Z4.aaa, are 
specified to become either an anchor cell (AC) or a ventral uterine cell (VU; Fig. 1). 
The AC/VU decision is mediated by the interaction between the receptor LIN-12 
(Notch) and its ligand LAG-2, therefore only one of the cells becomes an AC, and the 
other a VU. The HLH-2 (TCF3/E2A) transcription factor has been shown to directly 
activate lag-2 in the presumptive AC and to be post-transcriptionally downregulated 
in the presumptive VU cell via a negative feedback mechanism (Karp and Greenwald, 
2003). Another transcription factor, the C. elegans ortholog of the tailless nuclear 
receptor (nhr-67), is also implicated in Notch signaling and controls AC specification 
and development of the uterine π cells (Verghese et al., 2011). When AC fate is 
determined, six of the eleven ventrally located epidermal Pn.p cells (P3.p – P8.p) are 
specified as vulva precursor cells (VPCs) by LET-60 (Ras) and Wnt signalling 
pathways. During the L3 larval stage the AC induces development of the vulva by 
secreting the epidermal growth factor (EGF-like) ligand LIN-3 to the underlying 
VPCs so they adopt specific vulval fates (Hill and Sternberg, 1992). The VPCs 
express the EGF-receptor LET-23 (Aroian et al., 1990), but P6.p, which is in close 
proximity to the AC, receives the highest level of LIN-3, adopts a 1˚ cell fate and 
activates the LIN-12 signaling pathway in the flanking P5.p and P7.p to assume a 2˚ 
cell fate. The remaining three VPCs (P3.p, P4.p and P8.p) that receive insufficient 
inductive or lateral signals adopt a 3˚ cell fate, divide once and fuse with the syncytial 
hypodermis (hyp7). After three rounds of divisions, P5.p-P7.p produce 22 vulval cells 
of seven different types (vulA, vulB1, vulB2, vulC, vulD, vulE, and vulF), which fuse 
with each other to form seven toroidal rings, connect to the uterus and evert during 
the last molt to finally form the mature vulva. After induction of the VPCs at the 
beginning of the L3 larval stage, the AC invades the basement membrane separating 
the uterine tissue from the underlying developing vulva (Sherwood and Sternberg, 
2003). This process is initiated by the formation of F-actin-based invadopodia 
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enriched for the netrin receptor UNC-40 (Hagedorn et al., 2013). The integrin INA-
1/PAT-3 promotes membrane association of UNC-40, phospholipid PI(4,5)P2, the 
RacGTPase MIG-2 and F-actin to the invasive cell membrane of the AC (Hagedorn et 
al., 2009), while secretion of UNC-6 (netrin) from the ventral nerve cord (VNC) 
guides these components towards the invasive membrane (Ziel et al., 2009). 
Moreover, cell autonomous signaling of AC, via transcription factor FOS-1A activity, 
is necessary for basement membrane removal and AC invasion (Sherwood et al., 
2005).  
The AC also plays a crucial role in uterine morphogenesis. After induction of the 
central VPCs to adopt vulval fates, the AC signals via LAG-2 and LIN-12 to six of 
twelve VU descendants to adopt a π cell fate. The π cells divide once and differentiate 
into two classes; four cells will connect to the dorsal side of the vulva, and eight cells 
will fuse with the AC during the L4 larval stage and form an H-shaped uterine seam 
syncytium (utse) (Newman et al., 1996). The utse forms the ventral surface of the 
uterus. The two long sides of the H shape attach to the lateral seams and hold the 
uterus in place, while the central part forms a membrane between uterus and vulva, 
which is broken by the first egg leaving the uterus.  
Although the action of several conserved signaling molecules during vulval and 
uterine morphogenesis is now well established, it is also clear that several pieces are 
still missing. For instance, LAG-2 is repeatedly used to first specify the AC and then 
by AC to induce π cells, as well as in signaling between VPCs, indicating the 
existence of intricate regulatory networks. In contrast, several cues are involved in the 
correct timing of AC invasion. We have recently described that mutation of vrk-1 
delays anchor cell invasion and abolishes formation of the uterus lumen and utse 
(Klerkx et al., 2009a).  
VRK-1 is a serine-threonine kinase homologous to the human vaccinia-related kinase 
1 (VRK1) and belongs to the casein kinase 1 super family. The VRK kinase family is 
composed of three proteins in vertebrates (VRK1-3), whereas C. elegans and 
Drosophila genomes encode a single ortholog (VRK-1 and nucleosomal-histone 
kinase 1, NHK-1, respectively) (Klerkx et al., 2009b). Human VRK1 phosphorylates 
several transcription factors including the tumor suppressor p53, c-Jun, ATF2 and 
CREB (Barcia et al., 2002; Kang et al., 2008; Sevilla et al., 2004a; Sevilla et al., 
2004b). Furthermore, VRK1 has a critical role in supporting both chromatin and 
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nuclear envelope structure by phosphorylating barrier-to autointegration factor (BAF-
1 or BANF1) (Gorjanacz et al., 2007; Lancaster et al., 2007; Wiebe and Traktman, 
2007). In the absence of VRK1 in C. elegans embryos and human cells, BAF-1 
remains chromosome-bound upon mitotic entry and defects in chromosome 
segregation are observed (Gorjanacz et al., 2007; Kim et al., 2013b; Lancaster et al., 
2007; Molitor and Traktman, 2014; Wiebe and Traktman, 2007). Interestingly, both 
inhibition of VRK1 in flies and worms (Cullen et al., 2005; Gorjanacz et al., 2007), as 
well as overexpression of VRK1 in mammalian cells, lead to hypercondensed 
chromatin (Kang et al., 2007). 
Based on single-copy transgenic strains, we report here that C. elegans VRK-1 is 
more ubiquitously expressed than previously described. We observe that single-copy 
transgenes rescue vrk-1 mutant phenotypes more efficiently than multiple-copy 
transgenes, suggesting that they reflect endogenous levels more accurately. 
Furthermore, we show that VRK-1 plays a crucial role in uterine development, 
including π cell specification and proliferation, as well as AC fusion.  
 
2. Materials and Methods 
2.1 Nematode strains and transgenesis  
C. elegans strains were maintained using standard techniques (Brenner, 1974) and are 
listed in Supplementary Material Table S1. Single copy transgenic strains were 
generated by Mos1-mediated single-copy insertion into locus cxTi10882 of strain 
EG5003 (Frokjaer-Jensen et al., 2008). Integrated strains were outcrossed to wild type 
N2 twice. Absence of Mos1 transposon was confirmed by genotyping PCR.  
 
2.2 Plasmids 
Plasmids pBN962, pBN961 and pBN1047 with C-terminally located fluorescent tags 
(GFP, mCherry and Dendra2, respectively; codon-optimized for C. elegans and 
harboring artificial introns) for single-copy expression of VRK-1 contain 870 bp 
upstream from the vrk-1 start codon and 1494 bp downstream from the stop codon. 
Fluorescent tags were inserted into an engineered BsrGI site immediately before the 
stop codon. Plasmid pBN1028 encoding VRK-1 K169E::mCherry was derived from 
	 5	
pBN961 by PCR-stitching to modify vrk-1 codon number 169 from AAG (K) to GAG 
(E). Plasmid pBN90 for tissue-specific expression of VRK-1 contains 2194 bp fos-1c 
promoter sequence upstream of the vrk-1 ORF with C-terminally located mCherry 
and 301 bp emr-1 3'UTR. Detailed cloning information is available upon request. 
 
2.3 Live imaging 
For acquisition of single still images, animals were mounted in a 5 μL drop of 10 mM 
levamisole (tetramisole hydrochloride; Sigma-Aldrich cat. no. L9756, St. Louis, MO, 
USA) on a 3% agarose pad, covered with a 24 mm × 24 mm coverslip.  For long-term 
imaging, animals were incubated for 30 minutes in 167 μM levamisole, 1.67 mM 
tricaine (ethyl 3-aminobenzoate methane sulfonate salt; Sigma-Aldrich cat. no. 
A5040) and then mounted in a 5 μL drop of 167 μM levamisole, 1.67 mM tricaine on 
a 3% agarose pad, covered with a 24 mm × 24 mm coverslip and sealed with valap 
(1:1:1 mixture of Vaseline or petroleum jelly, lanolin, and paraffin; melts at 
60ºC). Epifluorescence and transmitted light images were acquired using a Nikon 
A1R confocal microscope through a Plan Apo VC 60x/1.4 objective (Nikon, Tokyo, 
Japan) or Leica TCS SP2 confocal microscope through a HCX PL APO 63x/1.4 
objective. Unless noted otherwise, all comparative images were acquired with 
identical settings. Quantitative analysis of fluorescence intensity and basal vs. apical 
polarity ratio after background subtraction were performed using ImageJ and Fiji 
software. Panels for figures were processed identically for optimal brightness and 
contrast using Fiji and Adobe Photoshop. 		
2.4 Rescue experiments  
Worms at the L4 stage were placed on NGM plates containing OP50 bacteria and 
transferred to fresh plates every 8-16 hours. After removal of the adults the number of 
embryos was scored. Fertile adults and Pvl phenotypes were scored after 72 hours. 
Experiments were performed at 20˚C. 
 
2.5 Statistical analysis 
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Data were analyzed by Student’s t-test using Microsoft® Excel® except for AC 
morphology (Fig. 4C) and AC fusion (Fig. 5B) experiments, which were evaluated by 
Fisher’s exact test. Probability values <0.05 were considered significant. 
 
3. Results 
3.1 VRK-1 is expressed throughout C. elegans  
We initially described postembryonic expression of VRK-1 based on transgenic 
VRK-1::GFP strains obtained by microparticle bombardment. Observations in these 
strains suggested that VRK-1 is enriched in neurons in the head and tail, ventral nerve 
cord (VNC), hypodermal cells and vulva precursor cells (VPCs) (Klerkx et al., 
2009a). Microparticle bombardment leads to integration of an unknown copy number 
of the transgene at a random position in the genome, which can affect the pattern and 
level of expression (Praitis, 2006). We reported that the VRK-1::GFP transgene 
introduced by microparticle bombardment reduced the protruding vulva (Pvl) 
phenotype of vrk-1 deficient mutants from 75% to 24%. However, adult animals 
remained sterile, presumably because the transgene was not expressed in the germ 
line (Klerkx et al., 2009a). To address this, we generated strains using the Mos1-
mediated Single Copy Insertion (MosSCI) method that leads to integration of a single 
copy transgene into a defined site and allows expression at endogenous level 
(Frokjaer-Jensen et al., 2008). We created three constructs for insertion in an 
intergenic region on chromosome IV, using GFP, mCherry or Dendra2 as fluorescent 
tags at the carboxyl terminus of VRK-1 followed by the vrk-1 3´UTR. Transgenes 
were expressed under control of the previously described vrk-1 promoter (Klerkx et 
al., 2009a). We first compared the single-copy vrk-1::GFP fusion gene with the strain 
obtained by bombardment with a similar vrk-1::GFP transgene. The single-copy 
transgene was expressed at much lower levels and in a more ubiquitous manner (Fig. 
2A, Supplementary Material Fig. S1A,B). Importantly, the three transgenes (vrk-
1::GFP, vrk-1::mCherry and vrk-1::Dendra2) showed identical expression patterns 
(Fig. 2A, Supplementary Material Fig. S1A). Nuclear expression was observed, not 
only in previously reported cells, but also in the anchor cell (AC), uterine tissue and 
germ line (Fig. 2A). Time-lapse recording of VPC and uterine cell divisions revealed 
that VRK-1 accumulates at the nuclear envelope at prophase and is associated with 
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chromosomes in anaphase (Supplementary Material Fig. 2, Video 1) as observed in 
embryos (Gorjanacz et al., 2007). Multi-copy transgenes are frequently silenced in the 
C. elegans germ line (Kelly et al., 1997), which could explain the lack of VRK-
1::GFP expression in the germ line in the strain produced by bombardment. However, 
even with the single-copy strains we observed considerable variability in germ line 
expression (ranging from 1/20 to 19/20 animals showing expression), but we note that 
this has been reported for MosSCI strains (Shirayama et al., 2012). 
 
3.2 Single copy vrk-1 transgenes rescue mutant phenotypes 
To test if the partial rescue by the bombardment-derived vrk-1::GFP transgene was 
due to the more restricted expression pattern, we analyzed the rescue efficiencies of 
the single-copy transgenes. We assayed the degree of rescue by counting worms with 
the Pvl phenotype and brood size (Fig. 2B). When they had reached adulthood, 
~100% of wild type hermaphrodites were fertile and did not show the Pvl phenotype. 
By contrast, 75% of vrk-1 mutants had a protruding vulva and 100% were sterile. 
When we introduced single-copy transgenes into the vrk-1 background, we were able 
to observe not only a complete rescue of the Pvl phenotype, but also fertility recovery. 
While 78% and 42% of vrk-1 mutants of the strains expressing VRK-1::mCherry and 
VRK-1::Dendra2, respectively, were fertile, almost all vrk-1 mutants of the strain 
expressing VRK-1::GFP were sterile (Fig. 2B). The lowest rescue efficiency of the 
VRK-1::GFP fusion protein is likely to be due to the fact that the frequency of its 
expression in the germline was also the lowest (two independent lines; data not 
shown). 
We subsequently analyzed whether catalytic activity of VRK-1 is required for correct 
vulval development and fertility. Substitution of lysine 179 (K179) for glutamic acid 
(E) in the active site of human VRK1 disrupts its kinase activity (Vega et al., 2004). 
We introduced the equivalent mutation in VRK-1 (K169E) and generated a single-
copy vrk-1 K169E::mCherry transgenic strain. The mutated protein was expressed at 
similar levels and localized in a similar way to wild type VRK-1::mCherry (Fig. 2C). 
However, all vrk-1 mutants expressing VRK-1 K169E::mCherry are sterile and 70% 
have a protruding vulva (Fig. 2B), which supports the argument that VRK-1 functions 
as an active kinase during development of the reproductive organs in C. elegans.     
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3.3 VRK-1 regulates Anchor Cell morphology 
During vulval development the AC becomes polarized and breaches the basement 
membrane separating vulval and uterine cells. We have previously shown that VRK-1 
depletion delays AC invasion in 86% of vrk-1 mutants and disturbs the basal 
localization of the actin-binding protein moeABD (Klerkx et al., 2009a). The 
transcription factor FOS-1A is a key regulator of AC behavior, but FOS-1-
independent pathways are also required for proper AC invasion (Sherwood et al., 
2005). For instance, HLH-2, which is necessary for specification of AC and VU cells 
during the early L2 larval stage, is also implicated in the regulation of AC invasion by 
regulating in a partially FOS-1-independent manner the transcription of protocadherin 
(cdh-3), papilin (mig-6) and hemicentin (him-4) (Schindler and Sherwood, 2011). 
Because VRK-1 functions independently from FOS-1 (Klerkx et al., 2009a); 
(Supplementary Material Fig. S3) we examined whether VRK-1 regulates HLH-2 
expression. To minimize genotypic variability we compared vrk-1 homozygous 
mutants with heterozygous siblings, which develop as wild type animals. We 
measured the florescence intensity of GFP::HLH-2 in the AC at the P6.p 1-cell, 2-
cell, 4- cell and 6-8-cell stages; however, no differences were observed between 
control animals and vrk-1 mutants (Fig. 3A, B). These results suggest that VRK-1 
regulates AC invasion independently of the HLH-2 pathway.  
In order to decipher whether the vrk-1 mutation affects markers of AC polarization 
and invasion other than moeABD, we analyzed the localization of the netrin receptor 
UNC-40 (DCC) fused to GFP, the phospholipaseC-δ (PLCδPH) fused to mCherry, the 
beta-integrin subunit PAT-3 fused to GFP and finally MIG-2, a member of the Rho 
family of GTP-binding proteins, fused to GFP. We examined the polarity of the AC 
by measuring the average fluorescence intensity of the basal (invasive) versus apical 
(noninvasive) membranes of the AC. In control animals, UNC-40, MIG-2, PLCδPH, 
and PAT-3 accumulates at the invasive membrane of the AC (Hagedorn et al., 2009; 
Ziel et al., 2009). In vrk-1 mutants the fusion proteins were enriched at the invasive 
membrane of the AC to a similar degree to that in control animals, except PAT-3, 
which was slightly hyperpolarized (Fig. 4A, B). Interestingly, we observed that AC 
morphology was severely affected in vrk-1 mutants. While the apical side of the AC 
usually had a rounded dome shape in control animals at the P6.p 4-cell stage, it was 
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more irregular in vrk-1 mutants and cell protrusions were observed more frequently 
(Fig. 4A, C).   
 
3.4 Anchor Cell fails to fuse in C. elegans vrk-1 mutants 
The abnormal AC morphology in the absence of VRK-1 combined with the previous 
observation that the utse is not formed in vrk-1 mutants (Klerkx et al., 2009a) 
prompted us to investigate the AC fusion process. To this end, we assayed a cdh-
3::gfp reporter as marker of AC fusion (Hanna-Rose and Han, 1999; Pettitt et al., 
1996). CDH-3 is a member of the cadherin superfamily, which is implicated in cell 
adhesion, regulation of tissue organization and morphogenesis (Pettitt, 2005). The 
cdh-3 reporter expresses soluble GFP in the AC during the L3 larval stage and as the 
AC fuses with descendants of uterine π cells, GFP spreads from the AC cytoplasm 
throughout the utse cell (Hanna-Rose and Han, 1999). It is also expressed in VPCs 
and uterine epithelium closest to the invaginating vulva (Pettitt et al., 1996). As 
expected, we observed a strong fluorescence signal of cdh-3::GFP in the AC during 
the L3 stage, both in control animals and vrk-1 mutants (Fig. 5A). However, when the 
fusion of the AC during L3/L4 molt caused a dilution of the GFP signal in control 
animals, in most vrk-1 mutants (17/24) GFP was confined to the area of the AC, 
suggesting that the AC fails to fuse in vrk-1 mutants (Fig. 5A, C). A minor fraction of 
vrk-1 mutants (5/24) presented an ambiguous phenotype, resulting from abnormal AC 
morphology and cdh-3::GFP expression in the VPCs and, in lower levels, in other 
uterine cells.  
To confirm that the lack of AC fusion is a result of the vrk-1 mutation, we expressed 
VRK-1::mCherry specifically in the uterine tissue. As described above, vrk-1 does not 
regulate fos-1 expression, which facilitates using the fos-1c promoter that was 
identified as a uterine intermediate precursor enhancer (Oommen and Newman, 
2007). When we expressed low levels of VRK-1::mCherry from a single-copy 
transgene under control of the fos-1c promoter, we rescued the lack of AC fusion in 
vrk-1 mutants, as well as formation of the utse and the uterine lumen (Fig. 5B, C, 
Supplementary Material Fig. S4). These data confirmed that VRK-1 is necessary for 
fusion between the AC and uterine π cells and that VRK-1 expression in the uterine 
tissue is sufficient for this process.  
	 10	
 
3.5 Lack of VRK-1 causes proliferation and differentiation defects in uterine cells 
We next sought to determine the onset of uterine defects in vrk-1 mutants by 
analyzing the expression of HLH-2 and tailless ortholog NHR-67 during earlier 
developmental stages. The AC, as other uterine cells, is derived from cells of the 
somatic gonad primordium. In the L2 larval stage NHR-67 is expressed in the four 
pre-VU cells that become the AC and three VU cells (Verghese et al., 2011). 
Moreover, during AC/VU decision, HLH-2 is expressed in both Z1.ppp and Z4.aaa 
precursor cells and as AC/VU decision progresses, its expression is elevated in the 
presumptive AC to activate lag-2 transcription (Karp and Greenwald, 2003; Schindler 
and Sherwood, 2011). We found that all four pre-VU cells expressed NHR-67::GFP 
in both control animals and vrk-1 mutants (Fig. 6A) and the ratio of GFP::HLH-2 
expression between the presumptive AC and the adjacent VU cell was also normal 
(Supplementary Material Fig. S5). These observations suggest that initial 
specification of AC and VU linages is vrk-1 independent and that defects leading to 
abnormal AC morphology and behavior occur later in L3 larvae. 
We therefore analyzed the expression of EGL-13, a SOX domain transcription factor, 
fused to GFP. EGL-13 is controlled dually by FOS-1 and LAG-1 and is required for 
the maintenance of the uterine π cell fate (Oommen and Newman, 2007).  In 
concordance with our previous description of diminished LIN-11 expression, we 
observed a reduced number of cells expressing EGL-13::GFP upon loss of vrk-1, 
confirming abnormal uterine π cell specification in vrk-1 mutants (Fig. 6B). In order 
to decipher whether VRK-1 depletion affects proliferation of the uterine cells, we 
used HIS-72::GFP and EMR-1::mCherry to mark chromatin and nuclear envelopes, 
respectively. Affected morphology of the uterine tissue was described at the L4 larval 
stage (Klerkx et al., 2009a) but earlier stages have not been analyzed. We observed 
that both the number of uterine nuclei and their morphology were severely affected at 
early L3 larval stage (Fig. 6C). In control animals, uterine nuclei were surrounded by 
uniform EMR-1::mCherry signal, whereas they were smaller and with irregular EMR-
1::mCherry distribution in vrk-1 mutants. Later, at the L3/L4 molt, these defects were 
exacerbated, while neighboring vulva cells had normal morphology, demonstrating 
that uterine cells are more sensitive to loss of VRK-1 function (Fig. 6C). Similarly, 
using FOS-1::YFP to specifically visualize uterine cells also clearly indicated that the 
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number of FOS-1A::YFP expressing nuclei is lower in vrk-1 mutants (Fig. 6D). 
Single-copy expression of VRK-1 specifically in the uterine tissue, under control of 
the fos-1c promoter, rescued not only defects in the morphology and number of FOS-
1-expressing uterine cells, but also the Pvl phenotype (Fig. 6E, F). We did not observe 
rescue of the fertility, which agrees with the restricted expression of vrk-1 in the 
uterine cells, but not in the germ line, from the fos-1c promoter. From these 
observations we conclude that vrk-1 is necessary for proper proliferation and 
differentiation of uterine tissue in a cell autonomous manner. 
 
4. Discussion 
4.1 VRK-1 is expressed ubiquitously  
In this study we have shown that vrk-1 is ubiquitously expressed, including all vulva 
and uterine cells. Fusion between the AC and surrounding π cells to form the utse is 
inhibited in vrk-1 mutants, which causes a penetrant Pvl phenotype. The Pvl 
phenotype is efficiently rescued by fluorescent VRK-1 fusion proteins, but not by a 
kinase-dead VRK-1 K169E mutant, indicating that vulval development requires 
VRK-1 kinase activity. Notably, ectopic expression of vrk-1, specifically in uterine 
cells, efficiently rescues vulval and uterine development, suggesting that VRK-1 acts 
cell autonomously. This is in contrast to our previous conclusion that VRK-1 
expression in vulva cells regulates AC behavior in a cell non-autonomous manner 
(Klerkx et al., 2009a). This conclusion was based on two observations. Firstly, a vrk-1 
RNAi hairpin expressed from the lin-31 promoter in RNAi spreading-defective 
animals produced a Pvl and/or Egl phenotype with 20% penetrance. The lin-31 
promoter was chosen based on its activity in VPCs (Tan et al., 1998). However, 
others have reported a more broad expression pattern of lin-31 (Reece-Hoyes et al., 
2007), suggesting that vrk-1 could have been knocked down in several cell types. 
Secondly, microparticle bombardment-derived vrk-1::gfp transgenes that were 
expressed in the VNC and VPCs, but not in the AC and uterine tissue, restored uterine 
development in vrk-1 mutants. Microparticle bombardment typically produces higher 
expression than MosSCI, presumably because the former often introduces several 
copies of the transgene into the genome (Frokjaer-Jensen et al., 2008). Comparison of 
vrk-1 bombardment and MosSCI strains indeed revealed lower, but also more 
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widespread expression in the latter, including most proliferating and post-mitotic 
cells. Importantly, whereas the vrk-1 bombardment strain reduced the Pvl phenotype 
of vrk-1 mutants from 75% to 24% (Klerkx et al., 2009a), our new single-copy strains 
completely suppressed this phenotype. Germ-line expression and fertility was only 
rescued by the MosSCI strains. We therefore propose that the transgenic vrk-1 
expression pattern reported here more accurately reflects the behavior of endogenous 
vrk-1. Like many other C. elegans genes, vrk-1 is situated in an operon, which makes 
transgene construction more challenging. Although we expressed vrk-1 under control 
of the putative, directly upstream endogenous promoter, it is possible that it does not 
fully recapitulate the native expression pattern. To address this, we have repeatedly 
tried to use CRISPR/Cas9, a novel method of genome engineering (Waaijers and 
Boxem, 2014) to knock-in mCherry into the endogenous vrk-1 locus, however to date 
we have not succeeded. Moreover, we have raised several antibodies against VRK-1 
but none of them has worked satisfactorily in an immunohistological analysis of 
larval and adult tissues. 
Although we favor the possibility that endogenous vrk-1 is expressed in all uterine 
cells, including the AC, our earlier conclusion that AC invasion timing, as well as 
formation of the utse and the uterine lumen, could be rescued by cell non-autonomous 
overexpression of vrk-1::gfp, poses an interesting question: Does VRK-1 act in 
tissues surrounding the uterus (e.g. the developing vulva, intestine, hypodermis, etc.) 
to guide uterine development, or is the requirement for cell autonomous expression of 
vrk-1 in uterine cells, including the AC, so low that sufficient, but undetectable 
quantities might be expressed in the vrk-1 bombardment strain? The data presented 
here on ectopic vrk-1 expression from the uterine-specific fos-1c promoter, which 
expressed less VRK-1::mCherry than the vrk-1 promoter, suggests a cell autonomous 
role of VRK-1 in uterine cells, although it does not rule out a vrk-1-mediated 
contribution from other tissues. In any case, our results point to the need to be 
cautious about site-of-action studies, in particular with multi-copy transgenes.  
 
4.2 Control of cell morphology and fusion by VRK-1 
The actin-binding protein, moeABD, accumulates abnormally at the apical, 
noninvasive, membrane of the AC in vrk-1 mutants, suggesting a role of VRK-1 in 
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the pathways controlling AC polarization (Klerkx et al., 2009a). However, we did not 
observe differences in the asymmetric distribution of three other proteins involved in 
the AC polarization, and PAT-3 was only mildly mis-localized. PAT-3 is a beta 
subunit of integrin, which regulates F-actin recruitment at the cell membrane 
(Hagedorn et al., 2009), therefore we expected the apically accumulated moeABD in 
vrk-1 mutants to coincide with increased amounts of PAT-3 at the apical AC 
membrane. However, quantification of PAT-3 polarity suggested a mild 
hyperpolarization of the basal membrane of the AC in vrk-1 mutants. Upon depletion 
of VRK-1, morphology of the uterine cells, including the AC, is affected, whereas the 
vulva tissue is normal. Rather that having a typical smooth dome-shaped apical side, 
the AC was frequently characterized by long protrusions in vrk-1 mutants. The apical 
accumulation of moeABD in vrk-1 mutants might therefore reflect abnormal 
actomyosin cytoskeleton distribution induced by irregular contacts between the AC 
and other uterine cells rather than AC mis-polarization. Signaling from the AC to 
uterine cells is required in order for the latter to adopt the π cell fate, however, π cell 
markers are not correctly expressed in vrk-1 mutants (Klerkx et al., 2009a) (and this 
study). Perhaps as a consequence hereof, the AC does not fuse to its neighboring 
uterine cells and the utse is therefore not formed, ultimately causing protrusion of the 
vulva. Importantly, as indicated above, expression of vrk-1 specifically in the uterine 
cells (including the AC), was sufficient to rescue both AC fusion and the Pvl 
phenotype.  
 
4.3 VRK-1 and cell cycle control 
RNAi against vrk-1 leads to early embryonic lethality (Gorjanacz et al., 2007), 
however, homozygous vrk-1 mutants produced by heterozygous hermaphrodites are 
viable and do not show any evident defects until the early L3 larval stage, which can 
be explained by the maternal contribution of mRNA and protein. We show in this 
study that fates of both AC and VU cells are properly specified during the L2 larval 
stage in the absence of VRK-1, but the morphology of uterine nuclei is severely 
affected at the early L3 larval stage, prior to uterine morphogenesis. Moreover, 
mitotic progression and morphology of germ line nuclei is also disrupted in vrk-1 
mutants (Waters et al., 2010). However, we also note that nuclear appearance of 
VPCs, which continue to divide after the uterine cell division and morphology defects 
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described here, is not affected in vrk-1 mutants (Klerkx et al., 2009a) (and this study). 
This suggests that VRK-1 might regulate cell proliferation in a cell-type specific 
manner, involving both nuclear envelope disassembly (Gorjanacz et al., 2007) and 
cell cycle progression (Waters et al., 2010). The role of VRK-1 in the cell cycle is 
likely to be evolutionary conserved. For instance, inhibition of VRK1 in human cell 
cultures causes a block in progression from the G1 to S phase and its expression 
parallels that of c-myc and c-fos, which are early response genes (Valbuena et al., 
2008). Moreover, VRK1 regulates cell cycle progression by phosphorylation of the 
cAMP-response element-binding protein and increasing cyclin D1 expression (Kang 
et al., 2008). These activities of VRK1 are likely to have tissue-specific implications, 
as reduction of VRK1 expression in mice is linked to gametogenesis defects and 
infertility (Schober et al., 2011; Wiebe et al., 2010). In concordance with VRK1’s role 
in controlling cell cycle progression and proliferation, several recent studies have 
identified VRK1 as an attractive target for development of new anti-cancer therapies 
(Baratta et al., 2015; Kim et al., 2013a; Kim et al., 2014; Riggi et al., 2014; Salzano et 
al., 2014). We propose that organogenesis in C. elegans might serve as a useful tool to 
evaluate the underlying mechanisms. 
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Figure Legends 
Fig. 1. Schematic representation of uterine development. (A) The AC/VU decision. 
The two central cells of somatic gonad primordium, Z1.ppp and Z4.aaa, are specified 
as anchor cell (AC) and ventral uterine (VU) cell.  Initially, both cells are equivalent 
and express LIN-12 (light blue) and its ligand LAG-2 (dark blue), however, stochastic 
differences in their expression are amplified by a positive feedback loop involving 
HLH-2. This leads eventually to a situation where one of the cells expresses 
exclusively LAG-2 and becomes the AC, whereas the other cells becomes a LIN-12-
expressing VU cell. (B) The AC (dark blue) signals via LAG-2 and LIN-12 to six of 
twelve VU descendants to adopt a π cell fate. (C-D) The π cells divide once 
producing twelve π cells. During L4 larval stage the AC fuses with eight π cells to 
form the syncytial uterine seam cell (utse). 
Fig. 2. Postembryonic expression of VRK-1. (A) Single-copy transgenic strain shows 
ubiquitous expression of VRK-1::mCherry. VRK-1 is expressed in neurons 
throughout the body, as well as in VPCs, AC (arrowhead), uterine tissue and germ 
line. Images were acquired using different microscope settings to compensate for 
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tissue-specific expression levels. Scale bar, 5µm. (B) Single-copy wild type vrk-1 but 
not kinase-dead vrk-1 K169E transgenes rescue vrk-1(ok1181) phenotypes. The 
number of fertile progeny and percentage of adults with Pvl are shown. Each circle 
represents the offspring from an individual founder (n=5-15 founders; 291-1335 
progeny scored for Pvl phenotype). Horizontal black lines and colored error bars 
report the mean and standard error of the mean, respectively. (C) Kinase-dead VRK-1 
K169E::mCherry is expressed and localized similarly to wild type VRK-1.   
Fig. 3. VRK-1 acts independently from the HLH-2 pathway. (A) Expression of 
GFP::HLH-2 green in merge) in control animals and vrk-1 mutants during P6.p 1-, 2-, 
4-, and 6-8 cell stages. Scale bar, 5µm. (B) Quantification of GFP::HLH-2 intensity in 
the AC in control (dark grey) and vrk-1 mutants (light grey). Average fluorescence 
intensity in vrk-1 mutants was not significantly different from control animals. Error 
bars report the standard error of the mean. 
Fig. 4. VRK-1 regulates anchor cell morphology. (A) Confocal images of control 
animals and vrk-1 mutants showing AC expression of UNC-40::GFP, 
PLCδPH::mCherry, PAT-3::GFP and MIG-2::GFP at the P6.p 4-cell stage. 
Arrowheads indicate abnormal AC protrusions. Scale bar, 5µm. (B) Quantification of 
UNC-40, PLCδPH, PAT-3 and MIG-2 polarization in control (dark grey) and vrk-1 
mutants (light grey) at the P6.p 4-cell stage.  Polarity in vrk-1 mutants was not 
significantly different from control animals, except for PAT-3::GFP (p=0.004). Error 
bars report the standard error of the mean. (C) AC morphology is severely affected in 
vrk-1 mutants (n=79) when compared with control animals (n=110), both in terms of 
cell body shape (upper graph) and presence of cell protrusions (lower graph) 
(p<0.001). 
Fig. 5. The anchor cell does not fuse in vrk-1 mutants. (A) Expression of cdh-3::GFP 
in control animals and vrk-1 mutants. At the L3/L4 molt GFP is expressed in the AC 
and some of the VPCs in both genotypes. At the early L4 stage the AC fuses with 
uterine π cells to form the utse in control animals resulting in diffuse cdh-3::GFP 
localization. By contrast, expression of cdh-3::GFP is limited to the area of the AC in 
vrk-1 mutants indicating lack of fusion. At mid L4 stage in vrk-1 mutants GFP is still 
retained in the AC. Arrowheads denote the AC. Images were acquired using different 
microscope settings to optimize GFP visualization. Scale bar, 5µm. (B) VRK-
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1::mCherry expression under control of the fos-1c promoter in uterine cells and AC 
rescues several vrk-1 phenotypes, including the AC fusion in early L4, formation of 
the utse in mid L4 and a uterine lumen. Arrowheads indicate the AC, whereas arrows 
point to the utse. Scale bars, 5µm. (C) Quantification of AC fusion in control animals 
and vrk-1 mutants. Lack of AC fusion was partially rescued by the uterine specific 
expression of VRK-1 under control of fos-1c promoter (p<0.001). 
Fig. 6. VRK-1 is essential for proliferation and differentiation of uterine tissue. (A) 
Expression of NHR-67::GFP in the four pre-VU cells is not affected in vrk-1 mutants 
at the L2 larval stage. (B) Lack of EGL-13::GFP expression demonstrates that uterine 
π cells are not properly specified in vrk-1 mutants at the L4 larval stage. (C) Lack of 
VRK-1 expression causes severe defects in proliferation and nuclear morphology of 
the uterine cells in early L3 and L3/L4 animals. EMR-1::mCherry (red in merge) and 
HIS-72::GFP (green in merge) visualize nuclear envelopes and chromatin, 
respectively. White arrowheads denote examples of uterine cells, whereas arrows 
point to vulva cells. (D) vrk-1 mutants at the early L3 larval stage have fewer and 
abnormally shaped nuclei expressing FOS-1A::YFP, indicative of defects in the 
proliferation and differentiation of uterine cells. (E) Uterine VRK-1::mCherry 
expression under control of the fos-1c promoter rescues the proliferation and 
differentiation defects as well as the Pvl phenotype. Scale bars, 5µm. (F) Expression 
of VRK-1::mCherry in uterine cells rescues vrk-1 mutant phenotypes. The number of 
fertile progeny and percentage of adults with Pvl are shown. Each circle represents 
the progeny from a single founder (n=3-10). Horizontal black lines and colored error 
bars report the mean and standard error of the mean, respectively.    
Fig. S1. (A) Postembryonic expression of VRK-1. Single-copy transgenic strains 
show ubiquitous expression of VRK-1::GFP and VRK-1::Dendra2. VRK-1 is 
expressed in hypodermal cells and neurons throughout the body, as well as in VPCs, 
AC (arrowheads), uterine tissue and germ line. Still images were acquired using 
different microscope settings to compensate for tissue-specific expression levels. 
Scale bar, 5µm. (B) VRK-1::GFP is much more abundant in transgenic strain YL255 
generated by microparticle bombardment than in single-copy strain BN156 generated 
by MosSCI. Still images taken using identical microscope settings. Scale bar, 10µm.  
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Fig. S2. Expression of VRK-1 during vulval and uterine development. An vrk-1 
mutant L3 larva expressing VRK-1::mCherry was anaesthetized and observed by 
time-lapse confocal microscopy for a total a 6 hours. Series of 5 focal planes 
separated by 2 µm were acquired every 5 minutes and most relevant focal planes for 
each time point were manually selected to mount video 1. White arrowheads denote 
the AC, red arrowheads indicate VRK-1::mCherry accumulating at the nuclear 
envelope of cells entering mitosis and green arrowheads point to VRK-1::mCherry 
associated with chromatin during anaphase. Scale bar, 5µm. 
Fig. S3. VRK-1 acts independently from the FOS-1 pathway. (A) Expression of 
FOS1A::YFP in control animals and vrk-1 mutants during P6.p 1-, 2-, 4-, and 6-8 cell 
stages. Scale bar, 5µm. (B) Quantification of FOS-1A::YFP intensity in the AC at 
P6.p 1-, 2-, 4-, and 6-8 cell stages in control (dark grey) and vrk-1 mutants (light 
grey). Average fluorescence intensity in vrk-1 mutants was not significantly different 
from wild type animals. Error bars report the standard error of the mean.  
Fig. S4. Uterine-specific expression of VRK-1 under control of the fos-1c promoter 
during early and mid- L4 larval stages. White arrowheads denote uterine cells 
expressing VRK-1::mCherry, whereas arrows indicate the VPCs, which do not 
expression VRK-1::mCherry. Note that much less VRK-1::mCherry is expressed 
from the fos-1c promoter, when compared with the vrk-1 endogenous promoter (Fig. 
2A), suggesting that even very low VRK-1 expression in the uterine tissue is 
sufficient to support uterine and vulval development. Images were acquired on a 
NIKON A1R confocal microscope with 561 nm laser power=40%; HV gain=200, 
while images in Fig. 2A were acquired using laser power=10-15% and HV gain=180.  
Scale bars, 5µm. 
Fig. S5. Control animals and vrk-1 mutants expressing GFP::HLH-2 in presumptive 
AC and VU cells at the L2 larval stage were observed by confocal microscopy (A). 
(B) The ratio between the average fluorescence intensity in the presumptive AC vs 
VU cells in vrk-1 mutants was not significantly different from wild type animals. 
Scale bars, 5µm. Error bars report the standard error of the mean. 
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